Literature DB >> 1418830

Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density.

J Duggan1, S Kilfeather, E O'Brien, K O'Malley, J Nussberger.   

Abstract

Plasma renin activity (PRA) declines with age in normal individuals, but the effect of age on plasma angiotensin II (ANG II) is less clear. A decline in plasma ANG II with age could result in altered platelet ANG II receptor density since plasma hormone levels influence their target organ receptors. To investigate this possibility, PRA, plasma ANG II, and platelet ANG II receptor density were examined in 17 young, 12 middle-aged, and 14 elderly healthy normotensive volunteers. To assess whether hypertension altered receptor density, these variables were also examined in 23 hypertensive patients. In normotensives, there was a negative correlation between age and PRA (r = -0.43, P < .05), no significant change in basal plasma ANG II with age, and a weak positive correlation between age and ANG II receptor density (r = 0.34, P < .05). Multiple regression analysis revealed that the relationship between age and ANG II receptor density was independent of the associated rise in mean arterial pressure with age (P < .05). Platelet ANG II receptor density was not significantly related to PRA or plasma ANG II. ANG II receptor affinity did not change with age. Neither PRA nor ANG II receptor density or affinity differed between hypertensives and normotensives of similar mean age, but plasma ANG II was significantly lower in hypertensives compared with normotensives. We concluded that aging is associated with a decline in supine PRA. The small decrease in plasma ANG II was not significant. Platelet ANG II receptor density increased with age primarily due to a small group of elderly subjects with elevated receptor density. There was no change in ANG II receptor density or affinity in hypertensives despite apparently lower plasma ANG II in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418830     DOI: 10.1093/ajh/5.10.687

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

Review 1.  Sympathetic control of reflex cutaneous vasoconstriction in human aging.

Authors:  Jody L Greaney; Lacy M Alexander; W Larry Kenney
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

Review 2.  Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis.

Authors:  Manuel Ramírez; Isabel Prieto; Francisco Alba; Francisco Vives; Inmaculada Banegas; Marc de Gasparo
Journal:  Heart Fail Rev       Date:  2008-03-29       Impact factor: 4.214

3.  Pharmacokinetics and blood pressure response of losartan in end-stage renal disease.

Authors:  D A Sica; C E Halstenson; T W Gehr; W F Keane
Journal:  Clin Pharmacokinet       Date:  2000-06       Impact factor: 6.447

Review 4.  Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications.

Authors:  J H Bauer
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 5.  Hypertension, RAS, and gender: what is the role of aminopeptidases?

Authors:  María Jesús Ramírez-Expósito; José Manuel Martínez-Martos
Journal:  Heart Fail Rev       Date:  2008-01-24       Impact factor: 4.214

Review 6.  ACE inhibitors. Differential use in elderly patients with hypertension.

Authors:  Z H Israili; W D Hall
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

Review 7.  Changes in the renin-angiotensin-aldosterone axis in later life.

Authors:  J Belmin; B I Lévy; J B Michel
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

8.  'Fine-tuning' blood flow to the exercising muscle with advancing age: an update.

Authors:  D Walter Wray; Russell S Richardson
Journal:  Exp Physiol       Date:  2015-05-13       Impact factor: 2.969

9.  Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individuals: results from a randomized double-blind placebo-controlled trial.

Authors:  Sanjay Rajagopalan; Mbabazi Kariisa; Santo Dellegrottaglie; Robert L Bard; Christine Kehrer; Susan Matlow; William Daley; Bertram Pitt; Robert Brook
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

Review 10.  Renal Aging: Causes and Consequences.

Authors:  Eoin D O'Sullivan; Jeremy Hughes; David A Ferenbach
Journal:  J Am Soc Nephrol       Date:  2016-11-15       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.